CERYVYN THRAPEUTICS (OPTEY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 97 136 sessions, November 20, 2025 to July 14, 2026
- Largest daily move
- +588.5% close of January 16, 2026
Company Description
OPTEY has declined 8.9% so far this year. The last closing price was $0.0214.
For FY2025, CERYVYN THRAPEUTICS reported revenue of $25K with net income of -$162.8M. The company operates at a net profit margin of -651164.0%.
This page collects what Stock Titan holds for OPTEY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CERYVYN THRAPEUTICS (OPTEY) closed at $0.0214 on July 14, 2026. So far this year, the price has lost 8.9%.
OPTEY Metrics & Rankings
Price returns through July 14, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
CERYVYN THRAPEUTICS has filed 1 recent SEC filing, including 1 Form SCHEDULE 13G/A. The most recent filing was submitted on July 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OPTEY SEC filings →
Financial Highlights
CERYVYN THRAPEUTICS generated $25K in revenue in FY2025, and net income was -$162.8M, reflecting a -651164.0% net profit margin. The company generated -$158.6M in operating cash flow. With a current ratio of 0.22, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in CERYVYN THRAPEUTICS (OPTEY) currently stands at 9.8 thousand shares, representing 0.0% of the float. Since November 2025, short interest has decreased by 60.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for CERYVYN THRAPEUTICS (OPTEY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 7.7 days.